The mission of IDDI is to deliver clinical trials results that are scientifically accurate, validated and reproducible.

Main therapeutic areas

  • Oncology
  • Ophthalmology
  • Infectious Diseases
  • Cardiovascular


1991: BRUSSELS, BELGIUM : The International Institute for Drug Development (ID²) was established in Brussels in 1991 by a team of experts in clinical trials, biostatistics, and biomedical computing.

1996: PARIS, FRANCE: The company expanded with the opening of an office in Paris. The company offered data management services out of its Paris office and biostatistical services out of its headquarters in Brussels.

2001: CAMBRIDGE, MA, USA: The company was renamed IDDI and opened an office in Cambridge, MA, to offer sophisticated web-based services for clinical trials supported by a dedicated help desk on both sides of the Atlantic Ocean.

Today: With over 20 years experience, IDDI is appreciated as a valuable partner in the design, conduct and analysis of clinical trials through optimal design, innovative methodology and state-of-the-art technology that help achieve time savings and cost-effective clinical trial processes.

Head Office
Avenue Provinciale, 30 1340 Louvain-la-Neuve, Belgium